Answers are grounded in this paper and cite their sources.
when determining the fill volume required to deliver a drug to a patient. 9 The aim of nebuliser therapy is to deliver a therapeutic dose of the desired drug in the form Fill volume: the volume of drug solution initially put into the nebuliser chamber. It must exceed of an aerosol of respirable particles within a fairly short period of time, usually the residual volume by a sufficient amount to provide therapeutic benefit to the patient. 9 It is 5-15 minutes. To achieve this, nebuliser systems should be expected to provide a drug suggested that it should be at least twice the residual volume. It is important to be aware output with about 50% of the particles below 5.0 m mass median diameter. It is important of the desirable fill volume when prescribing nebuliser drugs in prepackaged ampoules. to obtain an acceptable range of aerosol particle sizes because of the way in which these are
No takes yet. Share an insight, caveat, or question.
Kendrick et al. (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: